PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012
This is a continuing activity. The World Health Organization (WHO) has had a close working relationship with the Ethiopia Federal Ministry of Health (FMOH) since the early days of the HIV/AIDS epidemic. WHO has been providing technical assistance to FMOH and Regional Health Bureaus (RHBs) to strengthen the delivery of a national comprehensive response to the HIV/AIDS epidemic. Primarily, WHO has supported the development of national policies and guidelines, training manuals and training of trainers programs, and building capacity for TB and HIV control at national and regional level. WHO also plays a key role in keeping the national technical working groups (TWGs) active and functional for improved mobilization and coordination of technical and financial resources at the national-level. WHO as a global directing and coordinating UN health agency will continue to work with the FMOH to identify research priorities and generate information to better inform programs. WHO will continue to assist FMOH to enhance capacity and leadership skill at central and program level and will assist and give guidance to FMOH to design appropriate evidence based disease control strategies. WHO's activities are in full support of the goals of the GOE's National Strategic Plan (SPMII) and are aligned with the goals of the GOE and USG HIV/AIDS Partnership Framework and Global Health Initiative.
Global Fund / Programmatic Engagement Questions
1. Is the Prime Partner of this mechanism also a Global Fund principal or sub-recipient, and/or does this mechanism support Global Fund grant implementation? Yes2. Is this partner also a Global Fund principal or sub-recipient? Neither3. What activities does this partner undertake to support global fund implementation or governance?
Budget Code Recipient(s) of Support Approximate Budget Brief Description of ActivitiesHVTB WHO 600000 Provision of Technical assistance on the implementation of Global fund TB/HIV program.
In prior years, WHO in collaboration with the FMOH led the national TB program review and provided technical assistance for the implementation of the second round national TB prevalence survey and supported Oromia and Amhara regions to implement TB infection control interventions including procurement of supplies. In addition, WHO seconded four TB/HIV program officers to provide technical assistance for the TB/HIV programs at the national-level and to three regional health bureaus. WHO also supported the MDR TB program and piloted Tuberculin Skin Test for pediatric TB diagnosis at selected facilities to assess feasibility and cost effectiveness. Under COP2012, WHO will:1. Support human resources for the TB/HIV program at both the national and regional-level by seconding TB program officers who will provide "hand on" technical assistance on the implementation, coordination and monitoring of TB/HIV and MDR TB program.2. Organize and mobilize international technical assistance to support the MDR-TB program evaluation and scale up and assist the national TB program in the development and revision of TB/HIV, MDR-TB and TB infection control related policy documents, guidelines, training manuals.3. Assist the FMOH in strengthening TB/HIV strategic information including maintaining and updating TB/HIV information on the FMOH website.4. Assess the feasibility of introducing gastric aspirate, string testing and induced sputum and other technologies at selected hospitals to improve diagnosis of TB among children.5. Support the revision of TB diagnostic algorithms incorporating new diagnostic technologies.6. Work with the FMOH and regional health bureaus to advocate and promote TB infection control activities including development of regional infection control plans as well as standard operating procedures for health facilities, make periodic joint site assessment to oversee the status of TB infection control at health facilities and make recommendations for improvement.7. Coordinate and collaborate with other partners to supply N95 masks to MDR-TB treatment centers depending on the need.
WHO supported the development of the national blood policy and plan and its implementation and monitoring. WHO will provide technical assistance with the aim of establishing an efficient, sustainable, nationally coordinated blood transfusion services that can assure the accessibility, quality, safety and adequacy of blood and blood products to meet the needs of all patients requiring transfusion in Ethiopia. WHO will support the implementation of blood safety in the following areas:1. National coordination and development of basic components for management of blood safety serviced will be supported through conducting planning and review meetings at national and regional levels. WHO will track the implementation of blood safety program at the NBTS /Addis Ababa Blood Bank.2. Enhancement of blood donor recruitment to meet national requirements for safe blood supply. This will be achieved through support to expand regular voluntary non-remunerated blood donors via development of strategies and plans for improved community mobilization. WHO will also improve communication mechanisms via training of journalists, community mobilisers and staff.3.Establishment of 27 mobile collection teams with the aim of collecting 120,000 units of blood in 2012.4. Support the training of trainers and mentors from USG universities and NBTS. About 81 individuals will be trained.5. Cost-effective quality testing and processing will be achieved through support in establishment and strengthening of the blood bank laboratory functions particularly in the regions. This will include scale up of component production and improved cold chain maintenance.6. Support the reduction of unnecessary transfusion to reduce wastage and avert adverse transfusion events and reactions by training clinic staff in the use of blood and safe bedside practices. WHO will conduct training of trainers courses for USG universities and regional staff.7. Strengthen systems for regular monitoring, evaluation, review and re-planning.8. Support the improvement of the quality management system and its roll out to the regions.
Scaling up of HIV care and treatment services requires the establishment of surveillance for HIV drug resistance (HIVDR). Because of the high mutation rate of HIV and the lifelong treatment of the disease, it is expected that some degree of HIVDR will occur among persons on treatment even if appropriate regimens are provided with good adherence. As part of ART scale-up, WHO is putting a system in place to assess ART program factors that may be associated with HIV drug resistance and to monitor the emergence of HIV drug resistant strains. WHO has supported the development of the national HIVDR strategy working group, HIV drug resistance Early Warning Indicators (EWI) survey, sentinel monitoring of HIV drug resistance in treated populations and associated ART program factors, threshold surveys to evaluate the transmission of HIV drug resistance, and the HIVDR database, as well as has provided support for the WHO-accredited HIVDR genotyping laboratory at EHNRI. Under COP2010/2011, WHO provided HIVDR training to facility and regional health bureaus staff in the five regions accounting for most HIV. WHO has also supported EHNRI on the EWI protocol development, data collection, processing and report writing. And WHO provided technical assistance to EHNRI in conducting ANC based HIV surveillance and STI/TB/HIV surveillance. Under COP2012, WHO will continue to:1. Provide technical assistance to EHNRI on HIVDR and EWI survey data collection, report writing and result dissemination;2. Support EHNRI data collection and analysis on HIVDR Threshold and Prevention Monitoring surveys in selected ART sites;3. Provide technical assistance to FMOH/FHAPCO to conduct pre-ART treatment adherence and outcome studies;4. Provide technical assistance on ANC, TB HIV/STI surveillance and PMTCT data assessments;5. Support the establishment of Visceral Leishmaniasis/HIV sentinel surveillance sites; and6. Provide support to FMOH/FHAPCO /EHNRI to conduct assessments and program review on HTC, ART, PMTCT, STI and MC.
